Viewing StudyNCT00001114



Ignite Creation Date: 2024-05-05 @ 10:23 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00001114
Status: COMPLETED
Last Update Posted: 2021-11-01
First Post: 1999-11-02

Brief Title: The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposis Sarcoma
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Sarcoma Kaposi
Keywords:
Name View
Interferon-alpha View
Sarcoma Kaposi View
Didanosine View
Drug Interactions View
Acquired Immunodeficiency Syndrome View